Related Experiment Video
Updated: Jun 10, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Clavulanic acid biosynthesis and genetic manipulation for its overproduction
Ju Yeon Song1, Susan E Jensen, Kye Joon Lee
1School of Biological Sciences, Seoul National University, Seoul 151-747, South Korea.
Clavulanic acid biosynthesis in Streptomyces clavuligerus involves a unique pathway and is regulated by gene clusters across three genomic loci. Genetic manipulation offers a route to improve this important β-lactamase inhibitor.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Clavulanic acid is a crucial β-lactamase inhibitor, vital for potentiating β-lactam antibiotics against bacterial infections.
- Its producer, Streptomyces clavuligerus, is industrially significant, making the elucidation of clavulanic acid biosynthesis a key research area.
- Understanding the biosynthesis is essential for optimizing production and developing new antimicrobial strategies.
Purpose of the Study:
- To review the current understanding of clavulanic acid biosynthesis in Streptomyces clavuligerus.
- To identify and discuss the gene clusters responsible for clavulanic acid production.
- To explore methods for improving clavulanic acid yield through genetic manipulation.
Main Methods:
- Review of existing literature on clavulanic acid biosynthesis.
- Analysis of genomic data pertaining to Streptomyces clavuligerus gene clusters.
- Discussion of genetic engineering techniques applied to clavulanic acid production.
Main Results:
- Clavulanic acid biosynthesis follows a distinct mechanism, differing from other β-lactam compounds.
- The relevant gene clusters are located in three distinct genomic regions within S. clavuligerus.
- Genetic manipulation strategies have been explored for enhancing clavulanic acid production.
Conclusions:
- The biosynthesis of clavulanic acid is complex and involves specific gene clusters.
- Further research into these gene clusters can lead to improved production of this vital antibiotic adjuvant.
- Genetic engineering holds promise for enhancing the clinical utility of clavulanic acid-based therapies.
Related Concept Videos
Production of Pharmaceuticals
Production of Antibiotics
Bioreactor Controls-III
Biosynthesis in Bacteria
Gene Regulation in Microbial Communities: Quorum Sensing
Biosynthesis of Nucleic Acids

